Company Number: 13786995

Analysis Date: 2025-07-20 17:00 UTC

Financial Health Assessment for SUNWOO OXFORD LTD. (as of 31 December 2023)

---

1. Financial Health Score: D

Explanation:
The company is currently showing significant financial distress, with negative net assets and worsening liquidity position. It has a substantial working capital deficit, indicating it owes much more in short-term liabilities than it holds in current assets. This grade reflects a critical need for financial intervention to restore health.

---

2. Key Vital Signs

Metric	2023 Value (£)	2022 Value (£)	Interpretation
Current Assets	274	3,981	Drastically reduced current assets, mostly cash.
Cash at Bank	273	3,280	Severe depletion of cash reserves, a worrying sign of cash flow stress.
Debtors	1	701	Very low receivables; may indicate low sales or collection issues.
Current Liabilities	20,507	7,859	Significant increase in short-term debts, including director loans and other creditors.
Net Current Assets	-20,233	-3,878	Negative working capital worsening sharply — a key symptom of liquidity strain.
Net Assets / Shareholders’ Funds	-20,233	-3,878	Negative equity, indicating accumulated losses and financial stress.
Employees	0	1	No employees in 2023, possibly reflecting downsizing or operational contraction.

---

3. Diagnosis

• Liquidity Crisis ("Weak Pulse"): The company’s liquid resources (cash and debtors) have nearly vanished, while current liabilities have ballooned by over 160% from 2022 to 2023. This imbalance shows an inability to meet short-term obligations, a classic symptom of financial distress.

• Negative Net Assets ("Body in Deficit"): The company’s net assets have deteriorated fivefold in one year, with shareholders’ funds deeply negative at over £20,000. This indicates accumulated losses exceeding invested capital, threatening solvency.

• Declining Operational Activity ("Flat Vital Signs"): The extremely low debtor balances and zero employees suggest minimal business activity or a pause in operations, which may be contributing to poor turnover and cash flow.

• Reliance on Director Loans ("Supportive IV Drip"): The appearance of a £648 director loan in 2023 indicates the company’s reliance on internal funding to sustain operations, a common lifeline but not a sustainable long-term solution.

• Small Company Status with Exemption from Audit ("Limited Diagnostics"): The company qualifies as a small entity and has not undergone audit scrutiny, which means risks or financial issues may be underreported or less visible.

---

4. Recommendations

• Immediate Cash Flow Management: Prioritize securing working capital through additional funding (equity or loans) or negotiating extended payment terms with creditors to relieve liquidity pressure.

• Operational Review and Restructuring: Assess business model viability and operational costs since the company has zero employees and minimal current assets. Consider strategic pivots to restore revenue generation.

• Director Engagement and Support: Given the director’s significant control and recent financial support, formalize a sustainable financial plan with clear milestones to restore solvency.

• Explore Formal Insolvency Advice: If liquidity does not improve, consider consulting insolvency professionals early to explore restructuring options and avoid forced liquidation.

• Enhanced Financial Reporting: Even though exempt from audit, adopting more rigorous internal controls and financial reporting can help diagnose problems earlier and improve stakeholder confidence.

---

Medical Analogy Summary

SUNWOO OXFORD LTD. is currently in a state akin to a patient with a dangerously weak heartbeat and low blood pressure—its cash flow is critically low, and its liabilities are overwhelming its assets, signaling an urgent need for financial intervention. Without prompt treatment to restore liquidity and operational health, the prognosis is poor, risking insolvency.

---